MEDICINE - CNN O TV

India’s first mRNA vaccine from Gennova gets DCGI approval India’s first mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19. The vaccine will be available for adults above 18 years of age. It is a two dose vaccine to be administered intramuscularly at 28 days apart. India, June 29, 2022: Gennova Biopharmaceuticals Ltd., a subsidiary of Emcure Pharmaceuticals Ltd., announc ed that its mRNA vaccine – GEMCOVAC™-19 - against COVID‑19 received the Emergency Use Authorization (EUA) from the office of the Drugs Controller General of India (DCGI). GEMCOVAC-19™ is the very first mRNA vaccine developed in India and only third mRNA vaccine to be approved for COVID-19 in the world. These vaccines are highly ...

The Elimination of Malaria in India cannot happen till the private sector actively participates in the fight! New Delhi, June 22, 2022: India has pledged to end malaria in India by 2030, as stated by the Honorable Prime Minister at the East Asia Summit in 2015, the nation has made immense progress in controlling malaria – we have recorded 86% decline in malaria cases and 79% decline in deaths between 2017 and 2021. We have now in the stage where elimination would be central to our efforts. Ending malaria and other mosquito-borne diseases in India requires engaging individuals, communities, the private sector, and policy makers to take ownership and join the fight. This thought was also echoed by the Honorable Minister of Health and Family Welfare, Dr. Mansukh Mandaviya, when he stated o...